Related Experiment Videos
Caffeine-Associated Cardiac Dysrhythmia During ECT: Report of Three Cases
Richard Jaffe1, Gillian Brubaker, William R. Dubin
1Philadelphia Psychiatric Center, Philadelphia, Pennsylvania, USA.
Insights
Caffeine use during electroconvulsive therapy (ECT) may increase seizure duration but carries cardiac risks, especially in elderly patients with heart conditions. Non-pharmacologic alternatives and careful cardiac history review are recommended.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Caffeine is increasingly used in electroconvulsive therapy (ECT) to prolong seizures.
- Previous reports suggest potential adverse cardiovascular effects.
- The safety profile of caffeine augmentation in ECT requires further investigation.
Purpose of the Study:
- To report cases of severe cardiac dysrhythmia associated with caffeine use in ECT.
- To highlight the risks of caffeine augmentation in specific patient populations.
- To inform clinical practice regarding caffeine use in ECT.
Main Methods:
- Case series reporting three patients who experienced severe cardiac dysrhythmia.
- Review of patient history, focusing on age and pre-existing cardiac conditions.
- Analysis of the temporal relationship between caffeine administration and cardiac events.
Main Results:
- Three elderly patients with prior cardiac illness developed severe cardiac dysrhythmia during ECT with caffeine.
- All adverse events occurred in the presence of caffeine.
- These findings suggest a potential link between caffeine and cardiac complications in vulnerable patients.
Conclusions:
- Non-pharmacologic alternatives for seizure treatment should be considered.
- Thorough cardiac history evaluation is crucial before administering caffeine in ECT.
- Continued patient monitoring is essential when caffeine is used.
- Prospective studies are needed to precisely assess caffeine's risks in patients with cardiac disease.
Abstract:
Caffeine is increasingly being used by ECT practitioners to augment seizure duration in selected patients. We note one report of adverse cardiovascular effects with this procedure. We report three cases of severe cardiac dysrhythmia, all appearing in the present of caffeine. The three patients were elderly, with a prior history of cardiac illness. The authors recommend the use of nonpharmacologic alternatives for the treatment of brief seizures, and careful review of each patient's cardiac history before utilizing caffeine. They further urge continued monitoring in those patients for whom caffeine is introduced. Further prospective studies are needed to assess carefully the risk of caffeine pretreatment in patients with cardiac disease.